期刊文献+

rhEPO-Fc融合蛋白的表达、纯化及质量研究 被引量:7

High Expression, Purification, Quality Control of rhEPO-Fc Fusion Protein
在线阅读 下载PDF
导出
摘要 用无血清培养基培养分泌表达rhEPO-Fc融合蛋白的工程细胞株MY06(CHO细胞),收集发酵培养上清,通过离心、过滤、亲和层析、离子交换层析、分子筛等方法对目的蛋白进行纯化,通过lowry法、SDS-PAGE、Western-blot、HPLC、ELISA及IEF等方法研究目的蛋白质量,以建立rhEPO-Fc融合蛋白的发酵、纯化工艺,并探寻该融合蛋白的质量检测方法。通过该工艺,rhEPO-Fc蛋白表达量高达2g/L,蛋白纯化得率达45%以上,纯度可达98%以上,相对分子质量约为60kDa,t1/2长达38h,免疫印迹证明具有天然EPO的免疫原性。研究结果表明该生产工艺可获得rhEPO-Fc的高效表达,纯化得率高,质量检验方法稳定可靠,适用于大规模生产。 To explore the technics for high expression, purification, quality control of recombinant human erythropoietin and IgG Fc fusion protein, rhEPO-Fc fusion protein expressed by CHO cells in serum-free medium was collected and purified with a three-step purification process-affinity chromatography, ion exchange chromatography and molecular sieve chromatography; and its quality was controlled by protein concentration, SDS-PAGE,Western-blot,HPLC,ELISA and IEF, et al. The research findings are that the expression output of rhEPO-Fc was highly reached 2g/L, the purify rate was over 45%, its purify was over 98%, its relative molecular weight is about 60kDa, t1/2 in vivo of rhEPO-Fc is over 38h, western blot analysis showed rhEPO-Fc has nature antigenicity. The expression output and purify rate of the produce technics is high, quality inspection methods are stability and reliable, which could be fit for in large-scale production of rhEPO-Fc.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2007年第6期6-9,共4页 China Biotechnology
基金 上海市创新基金资助项目(0602H1203)
关键词 重组人促红细胞生成素 免疫球蛋白Fc段 融合蛋白 发酵纯化工艺 质量研究 Recombinant huma The technics of fermentor and purify n erythropoietin Fc segment of immunoglo- bulin G Fusion protein Quality control
  • 相关文献

参考文献7

  • 1Krantz SB.Erythropoietin.Blood,1991,77(3):419~434
  • 2Capon DJ,Chamow SM,Mordenti J,et al.Designing CD4 immunoadhesins for AIDS therapy.Nature,1989,337(6207):525~531
  • 3Chamow SM,Ashkenazi A.Immunoadhesins:principles and applications.Trends Biotechnol,1996,14(2):52~60
  • 4Landolfi NF.Chimeric ligand/immunoglobulin molecules and their uses.US Patent No.5,349,053.1994-09-20
  • 5Smith CA,Goodwin RG,Beckmann MP.Tumor necrosis factor-alpha and beta receptors US Patent No.6,224,867.2001-05-01
  • 6Kaufman RJ,Davies MV,Wasley LC,et al.Improved vectors for stable expression of foreign genes in mammalian cells by use of the untranslated leader sequence from EMC virus.Nucleic Acids Res.1991,25,19(16):4485~4490
  • 7贾茜,景红,田雪虹,谭丽霞,齐晓波.国外重组人红细胞生成素产品的体内外生物学活性测定[J].中国生化药物杂志,2000,21(4):184-186. 被引量:6

二级参考文献6

  • 1陈宝梁.国际血液学标委会推荐的网织红细胞活体染色显微计数法[J].中华医学检验杂志,1993,16(4):196-196.
  • 2王菁舟,中国生物制品学杂志,1997年,10卷,1期,45页
  • 3中华人民共和国药典委员会,中华人民共和国药典.二部,1995年,附录ⅪⅤ,110页
  • 4陈宝梁,中华医学检验杂志,1993年,16卷,4期,196页
  • 5全国中等卫生学校试用教材《临床检验》编写,临床检验,1980年,39页
  • 6王箐舟,程雅琴.检测EPO体内生物学活性的网织红细胞法的建立[J].中国生物制品学杂志,1997,10(1):45-48. 被引量:11

共引文献5

同被引文献126

  • 1萨姆布鲁克J,拉塞尔D W,黄培堂,王嘉玺,朱厚础,等译.分子克隆实验指南[M]3版.北京:科学出版社,2002..
  • 2Yousef GM, Diamandis EP. An overview of the kallikrein gene families in humans and other species: emerging candidate tumor markers. Clin Biochem, 2003, 36(6): 443.
  • 3Fukushima D, Kitamura N, Nakanishi S. Nucleotide sequence of cloned cDNA for human pancreatic kallikrein. Biochemistry, 1985, 24(27): 8037-8043.
  • 4Barker AR, Shine J. Human kidney kallikrein: cDNA cloning and sequence analysis. DNA, 1985, 4(6): 445-450.
  • 5Chao J, Woodley C, Chao L, et al. Identification of tissue kallikrein in brain and in the cell-free translation product encoded by brain mRNA. J Biol Chem, 1983, 258(24): 15173-15178.
  • 6Nolly H, Scicli AG, Scicli G, et al. Characterization of a kininogenase from rat vascular tissue resembling tissue kallikrein. Circ Res, 1985, 56(6): 816-821.
  • 7Evans BA, Yun ZX, Close JA, et al. Structure and chromosomal localization of the human renal kallikrein gene. Biochemistry, 1988, 27(9): 3124-3129.
  • 8Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev, 1992, 44(1): 1-80.
  • 9Pesquero JB, Bader M. Molecular biology of the kallikrein-kinin system: from structure to function. Braz J Med Biol Res, 1998, 31(9): 1197-1203.
  • 10Campbell DJ. The kallikrein-kinin system in humans. Clin Exp Pharmacol Physiol, 2001, 28(12): 1060-1065.

引证文献7

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部